English中文(简体)FrançaisEspañolالعربيةРусскийPortuguês

+86 0769 88380789

English
English中文(简体)FrançaisEspañolالعربيةРусский

Contact Us

  • Guangdong Unique Flavor Co., Ltd.
    • +86 18929267983info@cuiguai.com
  • Room 701, Building C, No. 16, East 1st Road, Binyong Nange, Daojiao Town, Dongguan City, Guangdong Province

    • Get samples now

    Whitelisting Ingredients: How to Add New Molecules to Approved Lists

    Author: R&D Team, CUIGUAI Flavoring Published by: Guangdong Unique Flavor Co., Ltd. Last Updated: Nov 09, 2026 WhatsApp & Telegram: +86 189 2926 7983 Email: info@cuiguai.com   Every flavor company eventually faces the same request: a customer wants a note that the current approved ingredient list cannot deliver. Perhaps the profile needs a softer green character, a longer cooling tail, or a baked note that survives heat. The R&D team finds a molecule that would solve the problem, and then the commercial conversation stalls, because no one can say with confidence whether the material can legally be used, whether the customer will accept it, whether it will remain stable in the base, or how long it will take to find out. A whitelist that is maintained properly converts that stall into a scheduled process with a known duration.   This article describes how an approved-ingredient list, often called a whitelist, should be built and how a new molecule is admitted to it. It is written from the perspective of a flavor manufacturer that supplies both e-liquid and food applications, where the regulatory frameworks differ, where customer restricted-substance lists add another layer, and where the analytical and toxicological evidence burden is real. The process described here is the one we operate, and it is designed so that a reasonable regulator, customer auditor, or technical reviewer could follow the trail from request to approval.

    What Whitelisting Means in a Flavor Company

    A whitelist is a controlled, versioned inventory of materials that the company has decided it may use. It is not a catalogue and it is not a shopping list. Each entry carries defined information: the substance identity including its registration or reference numbers, the accepted purity range, the permitted applications and markets, the maximum use level where one applies, the supplier or suppliers qualified to provide it, the specification and analytical methods, the supporting regulatory references, the approval date, the review date, and the status of any conditions attached to the approval. An entry without conditions and without a review date is an entry that nobody owns. For additional technical context on this point, see our cool flavor series.   The list has two audiences, and both must be served. Internally, it protects formulators from specifying something that cannot be purchased, documented, or defended, and it protects the business from a situation where a successful product cannot be sold into a market because one of its components is not permitted there. Externally, it is the evidence base for customer questionnaires, regulatory notifications, and audits. When a customer asks whether a substance is present in a flavor, the answer should come from a controlled record rather than from someone's recollection of a bench trial.   Whitelisting differs from formula approval. A whitelisted substance is permitted to be used; a formula is approved for a specific product, application, and market. A substance may be on the whitelist and still be excluded from a particular formula because the use level exceeds a limit, because a customer forbids it, or because it is incompatible with another component. Keeping the two decisions separate prevents the common error of assuming that whitelist status automatically authorises any use.

    Why the List Exists: Regulation, Safety and Customer Contracts

    Positive Lists in European and United States Frameworks

    Regulatory frameworks generally work by positive list. In the European Union, Regulation (EC) No 1334/2008 on flavourings establishes a Union list of flavouring substances permitted for use in and on foods, supported by evaluation work carried out by EFSA and by the Council of Europe's assessments of chemically defined flavouring substances. A substance that is not on a permitted list, or that is not covered by an applicable transitional provision, cannot be used simply because a supplier offers it. In the United States, substances used in food are typically either listed as approved food additives in the relevant parts of Title 21 of the Code of Federal Regulations or are recognised as GRAS for the intended use, and the FEMA GRAS assessments published by the Flavor and Extract Manufacturers Association are the industry's most widely referenced basis for flavour-use determinations.   E-liquid is a separate layer that many suppliers underestimate. Tobacco product regulation in Europe restricts e-liquid to a defined set of permitted ingredient categories, and requires ingredient reporting by weight. Tobacco product regulation in the United States requires ingredient disclosure in premarket submissions and imposes its own requirements on what may be added. A substance that is unobjectionable in a bakery application may therefore be unusable in an e-liquid, and the whitelist must record the permitted applications rather than assuming the approval travels with the molecule.

    Customer Restricted-Substance Lists

    Customers add a third layer by publishing their own restricted or prohibited substance lists, which are almost always stricter than statute. A customer may prohibit a solvent, require that a specific class of aroma chemicals be absent, demand that a material be free of a named allergen, or require declarations for substances above a reporting threshold. These lists change without much notice. A whitelisting system that records only regulatory status will fail customer audits, so the list structure should include per-customer restrictions and the ability to identify which formulas are affected when a customer tightens a threshold.

    The Commercial Cost of an Unlisted Ingredient

    The cost of using an unlisted ingredient is rarely borne at the moment of discovery. It appears later, as a reformulation project that must be completed within a customer's launch window, as a stability failure in a product already committed to a retailer, or as a notification that must be withdrawn and resubmitted because the ingredient disclosure was wrong. In the worst case, a finished product has to be recalled from a market because a component is not permitted there. Those costs dwarf the cost of running a proper approval process, which is why the whitelisting decision should be treated as a governance decision rather than a technical convenience.
    A flavour chemist prepares a candidate substance for identity and purity verification before it can be considered for the approved ingredient list.

    Identity and Purity Verification of a New Flavor Molecule | CUIGUAI Flavor

    The Seven-Stage Whitelisting Process

    The process below is sequential, but it is not slow by design. Most materials clear the early stages quickly, and the process is structured so that the expensive stages are entered only after the cheap stages have removed the materials that cannot succeed. That ordering is the difference between a whitelisting program that gates projects and one that delays them.

    Stage 1: Intake and Documentation

    A request enters through a standard form that captures the technical need, the proposed substance identity, the intended applications and markets, the required use level, the requesting formulator, and the target timeline. The requester attaches the supplier's technical data sheet, specification, safety data sheet, and regulatory status statement. A request submitted without a chemical identity cannot be assessed, and a request that identifies the material only by a trade name is returned, because trade names change and identities do not. The intake step also assigns a tracking number so that the request can be audited later, including the reason for any rejection.

    Stage 2: Identity and Purity Verification

    Identity is confirmed by comparing the declared name against a recognised chemical identifier and registry number, then verifying that the supplier's certificate of analysis for the actual batch is consistent with the identity claimed. Purity and impurity limits are reviewed against the specification, with particular attention to residual solvents, heavy metals, and any processing aid that may remain. Where a supplier reports a purity with an unexplained gap, or where the impurity profile is not characterised, the material is either rejected or approved only on the condition that a full impurity profile is supplied. This stage typically rejects the materials that were described in good faith but never properly characterised.

    Stage 3: Toxicological and Safety Screening

    Safety screening is proportionate to exposure. For a substance with an established acceptable intake, a published evaluation, or a recognised threshold-based assessment, the review can confirm that the intended use falls within the assessed range. For a substance with limited data, the assessment must consider whether a threshold of toxicological concern approach is defensible for the structural class, whether read-across from an analogous substance is supported, and whether the intended application involves inhalation or another route that changes the risk picture. Materials intended for inhalation applications carry a materially higher evidence burden, and a supplier's assertion of safety without supporting study data is not sufficient. For additional technical context on this point, see UFI codes and European poison centre notification.   This stage should also screen for hazards that are not captured by an acceptable intake figure. Respiratory sensitisation potential matters for any inhalable application. Genotoxicity alerts matter everywhere. Skin sensitisation matters where handling exposure is significant. Where an alert is present, the dossier should either address it with data or record a reasoned conclusion, and it should never be closed with a comment that the use level is low without specifying the basis for that conclusion.  

    Stage 4: Regulatory and Labelling Screening

    Regulatory screening answers three questions for each intended market: is the substance permitted, is the intended use level permitted, and what must be declared or notified? The assessment records the applicable positive list entry, any use-level restriction, and the labelling consequences, including allergen declaration, compositional disclosure, and notification obligations such as poison centre submission for hazardous mixtures. Where a mixture classification changes because of the new substance, the safety data sheet and the notification record must be updated before the modified formula is shipped.   Customer listings are screened in the same stage. The reviewer checks each affected customer's restricted-substance list, records any divergence from statute, and flags formulas that would need customer consent before the change is made. Recording the customer restriction at the whitelist level means a later query can be answered by filtering rather than by an all-hands investigation.
    A regulatory specialist reviews an ingredient dossier covering permitted status, use-level restrictions and labelling consequences in each target market.

    Regulatory and Labelling Screening for New Flavor Ingredients | CUIGUAI Flavor

    The Chemistry That Makes Whitelisting Hard

    Reactivity with Nicotine, Carriers and Other Aroma Materials

    A molecule can be perfectly permitted and still be unsuitable, because flavor systems are chemically active. Aldehydes react with alcohols and with amines; ketones can undergo aldol condensation under the wrong storage conditions; acids and bases shift the equilibrium of a nicotine-containing base and change both the sensory experience and the analytical picture. An ester added for a fruity top note may hydrolyse slowly in a propylene glycol and vegetable glycerine base, releasing an acid and an alcohol that were never intended to be present at the concentrations that result. Whichever molecule is being whitelisted, the assessment must state what it can react with, under what conditions, and what the resulting products are.   Interaction with the carrier matters as much as interaction with nicotine. Solubility determines whether the substance goes into solution or forms a haze. Polarity determines whether it partitions into the vapour phase at the temperatures the application uses, which is the difference between a flavor that works on a bench and one that works in the product. Volatility determines whether the material survives the process at all. A whitelist entry that does not record these compatibility findings will be used somewhere it fails.

    Impurities, Degradation Products and Shelf Life

    The impurity profile of a raw material is not a fixed property, because it depends on the supplier's route of manufacture. Two suppliers may offer the same declared substance at the same purity with materially different trace components, and those traces can matter at the concentrations used in flavor. For this reason a whitelist should qualify a substance with specific suppliers rather than qualifying the substance in the abstract, and a supplier change should trigger a re-review even when the material name does not change.   Degradation during storage is the second half of the problem. Accelerated and real-time stability work should establish how the substance behaves in the relevant matrix, at the relevant concentration, in the relevant packaging, over the declared shelf life. Where a degradation product is itself restricted or must be declared, the assessment must account for its formation over time rather than evaluating only the material as initially blended. This is the stage at which a technically elegant molecule is sometimes withdrawn, and it is far better to withdraw it during approval than after a customer has built a launch around it.

    Data Requirements: What a Complete Dossier Contains

    A complete dossier is a single controlled record that a reviewer who was not involved in the request can follow. It contains the request form and technical justification; the chemical identity with registry numbers and synonyms; the supplier specification with purity and impurity limits; certificates of analysis for representative batches, with the analytical methods stated; the safety assessment with its basis and any conditions; the regulatory status summary per market with references to the specific list or clause relied upon; the customer restriction screening result; the sensory and application test results including the matrix, concentration, and storage conditions; the compatibility findings for nicotine and carrier systems where relevant; the stability data; the supply chain assessment covering availability, lead time, and the second-source position; and the approval decision with its effective date, review date, and any conditions.   The method statements matter as much as the numbers. A purity figure reported without the analytical technique, the instrument, and the calibration basis cannot be reproduced or challenged, and an auditor will treat it as unverifiable. Where the identity of a natural material is at issue, the dossier should record the botanical source, the part of the plant used, and the isolation route, because these determine both the compositional variability and the regulatory classification of the material.
    A trained panelist evaluates a coded sample in an individual booth as part of the sensory and application testing required before whitelist approval.

    Sensory and Application Testing of a Whitelisted Ingredient | CUIGUAI Flavor

    Change Control After Approval

    Approval is not the end of the process. The whitelist entry should specify the conditions that trigger a re-review: a change of supplier or manufacturing site, a change of manufacturing route at an existing supplier, a change to the specification or an analytical result outside the historical range, a new market or a new application, a use level above the approved maximum, a change in customer restrictions, or the emergence of new safety or regulatory information. Each of these is a defined trigger, and the trigger should be owned by a named role rather than left to individual vigilance. For additional technical context on this point, see our vanilla cream flavor.   Supplier notification obligations should be contractual. A supplier that changes a raw material source, a solvent, or a purification step can alter the trace profile without altering the declared identity, and that change may invalidate our safety or stability conclusions. Requiring advance notification, with a defined response window, converts an invisible risk into a scheduled review. Where a change is material, the re-review should be treated as a new approval for the changed material rather than an amendment, because the evidence base has changed.   Version control is the mechanism that keeps the list trustworthy. Every entry carries a version number and an effective date; superseded versions are retained rather than deleted; and formulas reference a specific version of the whitelist entry at the time of approval. Without that linkage, a formula approved under an older entry can be reformulated inadvertently when the entry changes, and the discrepancy may only surface during an audit of a product already in the market.

    De-Listing: When and How to Remove an Ingredient

    Removing a substance is more disruptive than adding one, so de-listing should follow a defined process rather than a decision made in a single meeting. De-listing is triggered by a regulatory prohibition or restriction, a new safety finding, a customer prohibition, obsolescence of the material or its supplier, a persistent quality problem, or a commercial decision to simplify the portfolio. The first step is always an impact assessment: which formulas contain the substance, which customers and markets are affected, what stock exists, what regulatory notifications or safety data sheets reference it, and what reformulation lead time is genuinely required.   The exit should be staged. A new-use freeze prevents the substance from entering new formulas immediately. Existing formulas are then reformulated and revalidated in a sequenced order that prioritises the highest-risk or highest-volume products. Customer notification should precede any change in shipped material, with enough time for the customer's own revalidation and, where required, regulatory notification. De-listing should also record the reason and the evidence behind it, because a decision that is documented can be explained years later and a decision that is remembered in a meeting cannot.

    Common Mistakes in Whitelisting Programs

    The most frequent mistake is keeping the list in a spreadsheet that only one person understands and that has no version history. The second is approving a substance by trade name, which makes the approval meaningless when the supplier reformulates. The third is approving a substance for every application at once, which creates a false sense of coverage until a market-specific problem appears. The fourth is treating a supplier's GRAS statement or regulatory status letter as a substitute for an independent assessment, which it is not, because the supplier's assessment addresses the supplier's intended use rather than ours.   A fifth mistake is failing to connect the whitelist to the formula system. If a formulator can add a substance to a formula without a whitelist check, the control is voluntary. The connection should be enforced in the software or, where a paper workflow remains, by a documented second-person check before a formula is released. The sixth mistake is an approval without a review date, which allows an entry to remain in place long after the regulation or the safety assessment behind it has changed. The seventh is a list that is not exercised: an entry that has never been tested in the intended matrix is an assumption, not an approval.   Finally, programs often fail because they are designed only for rejection. A whitelisting process that says no efficiently but provides no route to a reasoned yes will be bypassed. The process should state its service levels, so that a requester knows how long a straightforward material takes, what happens when data are missing, and who can escalate a decision. Transparency about the path is what keeps the path in use.
    Pilot-scale blending followed by stability verification confirms that an approved ingredient performs in the intended matrix and packaging.

    Pilot-Scale Blending and Stability Verification for New Ingredients | CUIGUAI Flavor

    Frequently Asked Questions About Ingredient Whitelisting

    How long should approvals take? A straightforward substance with an established safety basis, a permitted regulatory status in the target markets, and complete supplier documentation can be approved in days once the dossier is complete. A novel substance requiring a full safety assessment, analytical characterisation, and stability work can take months. Publishing typical durations by category prevents unrealistic expectations.   Can we approve a substance for one market and not another? Yes, and the list should be structured that way. Market-specific approval is normal, because positive lists differ and because a substance may be permitted for food use but not for an inhalable application. The entry should state permitted markets explicitly rather than defaulting to global approval.   Is FEMA GRAS enough on its own? It is a strong and widely respected basis for flavour-use determinations in the United States, and it is referenced throughout the industry. It is not, by itself, a determination that a substance is permitted in every market or every application, and it does not replace the company's own assessment of the intended use, use level, and route of exposure. For additional technical context on this point, see heavy metal testing of flavor extracts and the ICP-MS limits buyers now request.   What if a customer prohibits a substance that is legally permitted? The customer restriction governs for that customer's products. The whitelist records the restriction, the formula system flags affected products, and the sales team is informed so that the product is not offered into that account in its current formulation. Divergence between statute and customer requirements is normal and should be managed by record rather than by argument.   How do we handle a natural material whose composition varies by harvest? Approve it with a composition range rather than a single point specification, define the analytical markers that must be monitored, and set acceptance criteria that reflect real seasonal variation. Where the variation exceeds what the application can tolerate, the material should be approved only for applications that are tolerant of the range, or standardised by the supplier to a defined profile.   Do we need to re-approve a substance when the supplier changes a purification step? Yes. A change of purification can change the impurity profile without changing the declared identity, which means the evidence supporting the approval may no longer describe the material being received. This is exactly the change that supplier notification clauses are designed to capture.   What documentation should accompany each shipment? At minimum, a certificate of analysis specific to the batch, generated from testing on that batch, with the specification limits stated and the release authorised by a named person. Where the market requires it, the shipment should also reference the current safety data sheet version and any applicable regulatory status statement. Retention of a representative sample allows later verification if a question arises.

    Conclusion: A Whitelist Is a Governance System, Not a Spreadsheet

    Adding a molecule to an approved list is a small decision with a long tail. It touches safety assessment, regulatory status in every market the product will reach, customer restrictions, chemical compatibility with nicotine and carrier systems, stability over shelf life, and supply continuity. A company that manages those dimensions through a defined, documented process can move quickly when the process is satisfied, because the evidence already exists and the decision is defensible. A company that manages them informally will find that its speed in development is repaid with delay in qualification and, occasionally, with a problem it cannot solve.   Our own ingredient approach is built on that process. It supports our cool flavor series, our vanilla cream flavor, and the rest of our portfolio with documented specifications and current regulatory status, and it connects to the notification and declaration work that customers need, including UFI codes and European poison centre notification and analytical expectations such as heavy metal testing of flavor extracts and the ICP-MS limits buyers now request. If a target note requires a molecule that is not yet on an approved list, the right first step is a conversation about the application, the market, and the timeline, so that the approval work can be scoped accurately rather than discovered halfway through development.  

    Request Samples and Technical Support

    Technical exchange/Free samples: 📞 Phone: +86 0769 8838 0789 🌐 Website: https://www.cuiguai.com 📧 Email: info@cuiguai.com 💬 WhatsApp & Telegram: +86 189 2926 7983

    References

    U.S. Food and Drug Administration. 21 CFR Part 172, Food Additives Permitted for Direct Addition to Food for Human Consumption. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-172   Food and Agriculture Organization of the United Nations and World Health Organization. JECFA Evaluations of Flavouring Agents and Food Additives. https://www.fao.org/food/food-safety-quality/scientific-advice/jecfa/en/   European Commission. Regulation (EC) No 1334/2008 on flavourings and certain food ingredients with flavouring properties for use in and on foods. https://eur-lex.europa.eu/eli/reg/2008/1334/oj   European Chemicals Agency. REACH Regulation and substance registration information. https://echa.europa.eu/
    For a long time, the company has been committed to helping customers improve product grades and flavor quality, reduce production costs, and customize samples to meet the production and processing needs of different food industries.

    QUICK LINKS

    PRODUCTS

    Friendship link

    CONTACT  US

  • Guangdong Unique Flavor Co., Ltd.
    • telegram +86 189 2926 7983info@cuiguai.com
  • Room 701, Building C, No. 16, East 1st Road, Binyong Nange, Daojiao Town, Dongguan City, Guangdong Province

    • ABOUT  US

    The business scope includes licensed projects: food additive production. General projects: sales of food additives; manufacturing of daily chemical products; sales of daily chemical products; technical services, technology development, technical consultation, technology exchange, technology transfer, and technology promotion; biological feed research and development; industrial enzyme preparation research and development; cosmetics wholesale; domestic trading agency; sales of sanitary products and disposable medical supplies; retail of kitchenware, sanitary ware and daily sundries; sales of daily necessities; food sales (only sales of pre-packaged food).

    Send Inquiry
    WhatsApp

    Request Inquery